[July 13, 2017] |
 |
Michigan's First Proton Facility
Proton International (PI) and Beaumont Health opened the state's first
proton therapy center today, offering the most advanced form of
radiation treatment available to people with a wide range of cancers.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20170713005265/en/
MICHIGAN'S FIRST PROTON FACILITY A Proton International Project at Beaumont Hospital in Royal Oak, MI (Photo: Business Wire)
"Our Department, which has long been known for technical innovations in
radiation oncology, today adds the latest in proton therapy to our
arsenal," says Craig Stevens, Chair of Radiation Oncology at Beaumont
Hospital. "It has been a pleasure working with all the teams in this
project. Proton International provided the needed proton-specific
expertise to building and operations to help us get off to a great
start!"
"This is a tremendous day for the people of Michigan," said Chris
Chandler, who founded Proton International in 2013 after developing,
opening and overseeing the operation of some of the first proton centers
in the United States and Europe. "Beaumont is joining a select group of
the nation's premier cancer treatment centers with this important option
for patients."
Beaumont is one of the few but growing number of proton centers to open
in the United States and the first for Michigan. The $40 million,
25,200-square-foot, two-story proton therapy building has a one-room
proton treatment facility on the first floor and the Beaumont Children's
Pediatric Oncology and Hematology program on the second floor. Proton
International participated in all phases of the development and opening
of the Center including the selection of equipment, the one room Proteus (News - Alert)
One technology from IBA. The facility incorporates advanced technology
from IBA including the S2C2 superconducting cyclotron.
Proton therapy is a precise alternative to X-ray radiation for treating
some cancer tumors. It spares healthy tissue adjacent to the tumor and
reduces or eliminates many of the short- and long-term treatment side
effects, making it particularly important when treating children whose
smaller size makes them vulnerable to damage from X-rays. Proton therapy
is especially effective in treating solid tumors including cancers of
the brain, central nervous system, eye, gastrointestinal tract, head and
neck, liver lung, prostate, spine and some breast tumors. Ongoing
research is enhancing the application of the therapy to additional sites.
It is conservatively estimated that some 250,000 cancer patients in the
U.S. alone could benefit from proton therapy, which is mainly being used
to treat solid cancer tumors.
Proton International www.protonintl.com
has an experienced team dedicated to bringing proton therapy to
patients. The company works with hospitals and physician groups to
develop one- and two-room proton therapy facilities, as well as larger
facilities, on a turnkey basis.
Proton International is currently participating in the development of
the following facilities:
-
The University of Alabama at Birmingham, Birmingham Alabama
-
Delray Medical Center, Delray Beach, Florida
-
University Medical Center Groningen, The Netherlands
-
University Hospital and the Radiation Clinic Halle, Halle (Saale),
Germany;
-
The University College of London Hospital.
The company's business model ensures that projects are completed on
time, on budget, and within the scope and needs of the Institution.
Services include business planning, organizational structure, financing,
building design and construction, installation and commissioning,
equipment, staff training and more.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170713005265/en/
[ Back To TMCnet.com's Homepage ]
|